Clinical trial · people
NMN: single oral doses up to 500 mg were safe in 10 healthy men
Checked against the paper Clinical trialPublished by PepVault
The takeaway
This early human study found single oral NMN doses of 100 to 500 mg caused no significant problems over 5 hours in healthy men and were broken down by the body, but it does not cover long-term use.
- Kind
- Clinical trial
- Studied in
- People
- Number studied
- 10
- Published
- 2020
- Journal
- Endocr J
What they tested
The team wanted to know whether a single oral dose of NMN is safe in healthy men and how the body breaks it down.
How the study was done
A single-arm, non-randomized trial with no comparison group, in 10 healthy Japanese men who each took single oral doses of 100, 250 and 500 mg of NMN. Each dose was followed by 5 hours of checks and blood sampling, with eye exams and a sleep quality score done before and after.

What they found
None of the NMN doses led to significant symptoms, and heart rate, blood pressure, oxygen saturation and body temperature did not change significantly. In blood tests, serum bilirubin went up and serum creatinine, chloride and blood glucose went down, but all stayed within normal ranges and the shifts did not depend on the dose. Eye exam results and sleep quality scores were the same before and after. Blood levels of two NMN breakdown products, N-methyl-2-pyridone-5-carboxamide and N-methyl-4-pyridone-5-carboxamide, rose significantly, and more so at higher doses.
What it doesn’t show
This was a very small trial in healthy men only, with no placebo group and no randomization. It looked at single doses over a few hours, so it says nothing about taking NMN daily or for weeks, and it did not test any health or aging benefit.
The paper
Irie et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J. 2020.
The compound
More studies on NMN
- NMN: no significant benefit on blood sugar or lipids in pooled trialsMeta-analysis · people · 2024
- NMN raised serum nicotinamide over 12 weeks in middle-aged adultsRandomized trial · people · 2023
- NMN (MIB-626) raised blood NAD levels in older adults over 14 daysRandomized trial · people · 2023
- NMN did not improve grip strength or walking speed in 24 weeksRandomized trial · people · 2023
- NMN: raised blood NAD over 60 days in 80 middle-aged adultsRandomized trial · people · 2023
- NMN supplements raised blood NAD+ levels in healthy older menRandomized trial · people · 2022
- Every study on NMN
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.